Clinical Trials Logo

Paracetamol Overdose clinical trials

View clinical trials related to Paracetamol Overdose.

Filter by:
  • None
  • Page 1

NCT ID: NCT03497104 Completed - Clinical trials for Paracetamol Overdose

The Markers and Paracetamol Poisoning Study 2

MAPP2
Start date: July 1, 2018
Phase:
Study type: Observational

Paracetamol overdose is one of the most common medical emergencies. Annually in the UK, 100,000 people seek medical attention and 50,000 need hospital admission. Treatment is with the antidote acetylcysteine (NAC), which is effective but takes 21 hours to administer intravenously and frequently produces adverse reactions. Current tools that are used to decide who needs treatment are inadequate. this trial team have identified and validated new blood tests that accurately identify those patients at risk of liver injury by quantifying the fundamental in vivo toxicity mechanisms. This study aim to gain further samples in order to develop a new point-of-care test specifically for the detection of liver damage.

NCT ID: NCT03177395 Completed - Clinical trials for Paracetamol Overdose

PP100-01 (Calmangafodipir) for Overdose of Paracetamol

POP
Start date: June 8, 2017
Phase: Phase 1
Study type: Interventional

Investigate the safety and tolerability of PP100-01 add-on treatment to the 12hr NAC treatment regime in patients treated for paracetamol/acetaminophen overdose (POD) when NAC treatment is initiated before 24hours post POD.